» Articles » PMID: 39597937

Identification of Predictors of Sarcopenia in Older Adults Using Machine Learning: English Longitudinal Study of Ageing

Abstract

After its introduction in the ICD-10-CM in 2016, sarcopenia is a condition widely considered to be a medical disease with important consequences for the elderly. Considering its high prevalence in older adults and its detrimental effects on health, it is essential to identify its risk factors to inform targeted interventions. Taking data from wave 2 of the ELSA, using ML-based methods, this study investigates which factors are significantly associated with sarcopenia. The Minimum Redundancy Maximum Relevance algorithm has been used to allow for an optimal set of features that could predict the dependent variable. Such a feature is the input of a ML-based prediction model, trained and validated to predict the risk of developing or not developing a disease. The presented methods are suitable to identify the risk of acquired sarcopenia. Age and other relevant features related with dementia and musculoskeletal conditions agree with previous knowledge about sarcopenia. The present classifier has an excellent performance since the "true positive rate" is 0.81 and the low "false positive rate" is 0.26. There is a high prevalence of sarcopenia in elderly people, with age and the presence of dementia and musculoskeletal conditions being strong predictors. The new proposed approach paves the path to test the prediction of the incidence of sarcopenia in older adults.

Citing Articles

Clinical Significance of Sarcopenia Defined by the Cross-Sectional Area of the Masseter Muscle in Cerebrovascular Events: A Retrospective Cohort Study.

Segmen F, Aydemir S, Kayan T, Bicer F, Dogu C, Aktekin E Medicina (Kaunas). 2025; 61(2).

PMID: 40005385 PMC: 11857208. DOI: 10.3390/medicina61020268.

References
1.
Steptoe A, Breeze E, Banks J, Nazroo J . Cohort profile: the English longitudinal study of ageing. Int J Epidemiol. 2012; 42(6):1640-8. PMC: 3900867. DOI: 10.1093/ije/dys168. View

2.
Studenski S, Peters K, Alley D, Cawthon P, McLean R, Harris T . The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014; 69(5):547-58. PMC: 3991146. DOI: 10.1093/gerona/glu010. View

3.
Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View

4.
Mayhew A, Amog K, Phillips S, Parise G, McNicholas P, de Souza R . The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2018; 48(1):48-56. DOI: 10.1093/ageing/afy106. View

5.
Veronese N, Smith L, Cereda E, Maggi S, Barbagallo M, Dominguez L . Multimorbidity increases the risk for sarcopenia onset: Longitudinal analyses from the English Longitudinal Study of Ageing. Exp Gerontol. 2021; 156:111624. DOI: 10.1016/j.exger.2021.111624. View